U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07233018) titled 'A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia' on Nov. 13.
Brief Summary: A Clinical Study to Investigate the Safety and Efficacy of CT0991 in Patients with Relapsed/Refractory Acute Myeloid Leukemia.
Study Start Date: Nov. 18
Study Type: INTERVENTIONAL
Condition:
Relapsed/Refractory Acute Myeloid Leukemia(AML)
Intervention:
DRUG: CT0991 CAR-T cells infusicn
CAR-T cells# chimeric antigen receptor T cells#
Recruitment Status: NOT_YET_RECRUITING
Sponsor: MEI HENG
Information provided by (Responsible Party): MEI HENG, Union Hospital, Tongji Medical College, Huazho...